RUSSELL ANGUS C. sold 5.1% of their position (4.72K shares) of LINEAGE CELL THERAPEUTICS, INC. on the open market
Open‑market sale worth $14.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/30/2021ACC: 0001493152-21-015786
Director
Since Jul 2018
-4.72K
Net shares
Net seller
$14.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
24.72K acquired · 29.44K disposed
Non-Derivative Transactions2
Common Shares, no par value
Direct
Shares
+24.72K
Price / share
$2.20
Trade value
$54.38K
% of position
36.6%
6/29/2021
67.50K→92.22K
Common Shares, no par value
Direct
Shares
−4.72K
Price / share
$2.97
Trade value
$14.02K
% of position
5.1%
6/29/2021
92.22K→87.50K
Total
Net shares
+20K
Net value
$40.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par value Direct | 6/29/2021 | M · Option Exercise | +24.72K | $2.20 | $54.38K | 36.6% | 67.50K | 92.22K |
| Common Shares, no par value Direct | 6/29/2021 | S · Sale | −4.72K | $2.97 | $14.02K | 5.1% | 92.22K | 87.50K |
| Total | +20K | $40.37K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Shares
24.72K shares
Shares
−24.72K
Strike price
2.2
Held after
0.00
Exercisable
—
6/29/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Shares24.72K shares | 6/29/2021 | M · Option Exercise | −24.72K | 2.2 | — | 0.00 |